Progyny, Inc.

PGNY Nasdaq CIK: 0001551306

Company Information

Industry Services-Misc Health & Allied Services, NEC
SIC Code 8090
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation DE
Business Address 1359 BROADWAY, NEW YORK, NY, 10018
Mailing Address 1359 BROADWAY, NEW YORK, NY, 10018
Phone 212-888-3124
Fiscal Year End 1231
EIN 272220139

Financial Overview

FY2025

Recent SEC Filings

Form Type Date Filed Document
SCHEDULE 13G/A Passive ownership amendment March 27, 2026 View on SEC
4 Insider stock transaction report March 19, 2026 View on SEC
8-K Current report of material events March 13, 2026 View on SEC
4 Insider stock transaction report March 6, 2026 View on SEC
4 Insider stock transaction report March 6, 2026 View on SEC
4 Insider stock transaction report March 4, 2026 View on SEC
4 Insider stock transaction report March 4, 2026 View on SEC
4 Insider stock transaction report March 4, 2026 View on SEC
4 Insider stock transaction report March 4, 2026 View on SEC
4 Insider stock transaction report March 4, 2026 View on SEC

Annual Reports

10-K February 27, 2026
  • Achieved robust financial performance in 2023 with 28% revenue growth to $910 million, $75 million net income, and $155 million Adjusted EBITDA.
  • Maintains a strong financial position with $220 million in cash and equivalents and minimal long-term debt.
View Analysis

Material Events

8-K Other January 12, 2026
High Impact
  • Progyny expects revenue, net income, and Adjusted EBITDA for Q4 and full year 2025 to be 'slightly above' earlier predictions.
  • The improved financial outlook is driven by favorable member engagement, indicating strong demand for Progyny's services.
View Analysis

Insider Trading

SELL 2 insiders 6 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 8090)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.